Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GLAXF) Gross Profit (2016 - 2025)

Historic Gross Profit for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $8.5 billion.

  • Gsk's Gross Profit rose 1629.2% to $8.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 billion, marking a year-over-year increase of 1012.84%. This contributed to the annual value of $28.5 billion for FY2024, which is 543.79% up from last year.
  • As of Q3 2025, Gsk's Gross Profit stood at $8.5 billion, which was up 1629.2% from $7.8 billion recorded in Q2 2025.
  • Gsk's Gross Profit's 5-year high stood at $14.3 billion during Q4 2024, with a 5-year trough of $4.8 billion in Q1 2021.
  • For the 5-year period, Gsk's Gross Profit averaged around $7.6 billion, with its median value being $6.8 billion (2024).
  • Per our database at Business Quant, Gsk's Gross Profit plummeted by 8043.96% in 2021 and then surged by 8708.25% in 2022.
  • Gsk's Gross Profit (Quarter) stood at $5.8 billion in 2021, then surged by 87.08% to $10.8 billion in 2022, then grew by 17.61% to $12.7 billion in 2023, then increased by 12.5% to $14.3 billion in 2024, then plummeted by 40.74% to $8.5 billion in 2025.
  • Its last three reported values are $8.5 billion in Q3 2025, $7.8 billion for Q2 2025, and $7.0 billion during Q1 2025.